Conjunctivitis in Novel Coronavirus Disease (COVID-19)
- PMID: 33281386
- PMCID: PMC7703821
- DOI: 10.4103/ijoem.IJOEM_85_20
Conjunctivitis in Novel Coronavirus Disease (COVID-19)
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
COVID-19: Precautionary Guidelines for Ophthalmologists.Cureus. 2020 Jun 25;12(6):e8815. doi: 10.7759/cureus.8815. Cureus. 2020. PMID: 32607305 Free PMC article.
-
Investigating the cases of novel coronavirus disease (COVID-19) in China using dynamic statistical techniques.Heliyon. 2020 Apr;6(4):e03747. doi: 10.1016/j.heliyon.2020.e03747. Epub 2020 Apr 4. Heliyon. 2020. PMID: 32289090 Free PMC article.
-
Conjunctivitis: A Systematic Review.J Ophthalmic Vis Res. 2020 Aug 6;15(3):372-395. doi: 10.18502/jovr.v15i3.7456. eCollection 2020 Jul-Sep. J Ophthalmic Vis Res. 2020. PMID: 32864068 Free PMC article. Review.
-
Advances in the treatment of novel coronavirus disease (COVID-19) with Western medicine and traditional Chinese medicine: a narrative review.J Thorac Dis. 2020 Oct;12(10):6054-6069. doi: 10.21037/jtd-20-1810. J Thorac Dis. 2020. PMID: 33209439 Free PMC article. Review.
Cited by
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- [Last accessed on 2020 Mar 16]. Available from: https://www.aao.org/headline/coronavirus-killschinese- whistleblower-oph... .
LinkOut - more resources
Full Text Sources